Medications for Mucklewells Syndrome

2 results
  • arcalyst - rilonacept injection, powder, lyophilized, for solution

    (Rilonacept)
    Kiniksa Pharmaceuticals (Uk), Ltd.
    Arcalyst treats Cryopyrin-Associated Periodic Syndromes (FCAS and Muckle-Wells Syndrome) in adults and children 12+, maintains remission of IL-1 Receptor Antagonist Deficiency (DIRA) in patients weighing ≥10 kg, and treats recurrent pericarditis to reduce recurrence risk in adults and children 12+.
  • ilaris - canakinumab injection, solution

    (Canakinumab)
    Novartis Pharmaceuticals Corporation
    Ilaris (canakinumab) treats periodic fever syndromes (CAPS, TRAPS, HIDS/MKD, and FMF) in adults and children, active Still's Disease (AOSD and SJIA) in patients 2 years and older, and gout flares in adults when NSAIDs and colchicine are contraindicated, not tolerated, or inadequate.